—

Smith & Nephew SNATS Inc (SNN) — the peer cohort

As of 2026-11-16 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Smith & Nephew SNATS Inc ranks 5 of 7 in its cohort on the Closelooknet composite (59/100) — the cohort is led by DexCom Inc at 63/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
SNN Smith & Nephew SNATS Inc 59 56 56 67 info 15.2%
DXCM DexCom Inc 63 70 79 36 watch 10%
CEVI.ST CellaVision AB 61 96 72 27 watch 1.2%
GMED Globus Medical 60 29 66 57 bear 28.9%
SECT-B.ST Sectra AB (publ) 60 83 67 10 bull 7%
SOON.SW Sonova H Ag 59 92 74 45 bull 2.6%
GKOS Glaukos Corp 51 96 28 14 ok 4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-16

Quick answers

Who are Smith & Nephew SNATS Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: DexCom Inc (DXCM), CellaVision AB (CEVI.ST), Globus Medical (GMED), Sectra AB (publ) (SECT-B.ST), Sonova H Ag (SOON.SW), Glaukos Corp (GKOS), as of 2026-11-16.

How does SNN score against its peers?

Smith & Nephew SNATS Inc's composite reads 59/100, ranking 5 of 7 in its cohort as of 2026-11-16; the cohort's highest composite is DexCom Inc at 63/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.